Tag: <span>Weight loss</span>

Home / Weight loss
Post

Fat cells have epigenetics-based memory: Researchers discover mechanism behind weight loss yo-yo effect

by Fabio Bergamin, ETH Zurich Human AT retains cellular transcriptional changes after BaS-induced WL. Credit: Nature (2024). DOI: 10.1038/s41586-024-08165-7 Anyone who has ever tried to get rid of a few extra kilos knows the frustration: the weight drops initially, only to be back within a matter of weeks—the yo-yo effect has struck. Researchers at ETH Zurich have now...

Post

New weight loss drug target burns energy and lowers appetite – without the nausea and vomiting

Peer-Reviewed Publication University of Copenhagen – The Faculty of Health and Medical Sciences Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or loss of muscle mass. The discovery was reported in the journal Nature and could lead to...

Post

New Oral Weight Loss Drugs: Where Are We and What’s Next?

Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring ahead with oral formulations, which promise a greater level of convenience, in line with patient preference. One particularly intriguing entry is ARD-101, in development by Aardvark Therapeutics in San Diego, California. Aardvark...

Post

Semaglutide boosts heart health, weight loss but may lead to gut problems

Semaglutide drugs aid weight loss and heart health but does that come at the expense of gut health? Image credit: Douglas Cliff/Getty Images. The diabetes medication semaglutide — sold under brand names including Ozempic, Wegovy, and Rybelsus — which has also gained popularity as a weight-loss tool, has another significant health benefit, a new meta-analysis suggests. Only Wegovy has...

Post

Unseen Cost of Weight Loss and Aging: Tackling Sarcopenia

Losses of muscle and strength are inescapable effects of the aging process. Left unchecked, these progressive losses will start to impair physical function.  Once a certain level of impairment occurs, an individual can be diagnosed with sarcopenia, which comes from the Greek words “sarco” (flesh) and “penia” (poverty). Individuals with sarcopenia have a significant increase...

Post

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

Novo Nordisk’s drug Wegovy, seen here at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois, has set a bar for obesity treatment that other companies hope to clear. Scott Olson via Getty Images Within the pharmaceutical industry, a multibillion-dollar race is underway to top Novo Nordisk’s and Eli Lilly’s in-demand obesity drugs. Dozens...

Post

New drug approach could underpin future weight loss therapies, study indicates

Credit: Pharmacological Research (2024). DOI: 10.1016/j.phrs.2024.107428 Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related diseases, new research has concluded. Mounting evidence suggests that hydrogen sulfide plays an important role in the liver. Previous research shows that tiny amounts of hydrogen sulfide in the body regulate...